Valbenazine
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 185 publications
Valbenazine Improves Quality of Life, Functionality, and Movement Severity in Patients With Tardive Dyskinesia: Findings From the KINECT-PRO™ Study.
Journal: CNS spectrums
Published: August 10, 2026
VMAT2 Inhibitors for Tardive Dyskinesia: What Psychiatrists Should Know.
Journal: Focus (American Psychiatric Publishing)
Published: August 01, 2026
Measuring What Matters: Further Validation for the Tardive Dyskinesia Impact Scale, a Novel Patient-Reported Outcome Measure in Valbenazine Clinical Trials.
Journal: The Journal of clinical psychiatry
Published: May 07, 2026
Green spectrofluorimetric method using nitrogen-phosphorus carbon quantum dots and Box-Behnken optimized salting-out assisted extraction for valbenazine determination in environmental samples.
Journal: Scientific reports
Published: April 21, 2026
Electroconvulsive Therapy for Severe Refractory Tardive Dystonia Without Active Depression: A Case Report.
Journal: Neuropsychopharmacology reports
Published: January 31, 2026
VMAT2 inhibitors for the treatment of tardive dyskinesia: a narrative review.
Journal: CNS spectrums
Published: October 22, 2025
Valbenazine induced acute parkinsonism in a patient with alcohol use disorder and central pontine myelinolysis.
Journal: PCN reports : psychiatry and clinical neurosciences
Published: October 11, 2025
Safety and efficacy of VMAT2 inhibitors in Huntington Disease: A systematic review.
Journal: Parkinsonism & related disorders
Published: September 26, 2025
Valbenazine for the Treatment of Chronic Motor or Vocal Tic Disorder (CMVTD).
Journal: Cureus
Published: September 19, 2025
Acute exacerbation of major depressive disorder following valbenazine treatment for tardive dyskinesia: A case report.
Journal: PCN reports : psychiatry and clinical neurosciences
Published: August 14, 2025
Consultation-Liaison Case Conference: Stimulant-Induced Tardive Dyskinesia.
Journal: Journal of the Academy of Consultation-Liaison Psychiatry
Published: August 13, 2025
Efficacy and Safety of VMAT-2 Inhibitors and Dopamine Stabilizers for Huntington's Chorea: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.
Journal: Medical sciences (Basel, Switzerland)
Published: August 01, 2025
Last Updated: 09/26/2026